Aims Troponin-positive chest pain patients with unobstructed coronaries represent a clinical
dilemma. Cardiovascular magnetic resonance (CMR) imaging has an increasingly …

Cardiac troponins are the preferred biomarkers for diagnosis of myocardial infarction
because of their high sensitivity and specificity for myocardial injury. However, acute and …

Aims Our aim was to test the prediction and clinical applicability of high-sensitivity assayed
troponin I for incident cardiovascular events in a general middle-aged European population …

Background We aimed to investigate changes of incidence, outcome and related
interventions of patients with acute coronary syndrome (ACS) over the past decade in …

Background High-sensitivity cardiac troponin (hs-cTn) may allow an earlier diagnosis of
acute myocardial infarction (AMI). Methods We prospectively enrolled 1148 (derivation …

Objective To evaluate how selection of patients for high sensitivity cardiac troponin testing
affects the diagnosis of myocardial infarction across different healthcare settings. Design …

Immunoassays measuring cardiac troponins I or T have become firmly established as critical
tools for diagnosing acute myocardial infarction. While most contemporary assays provide …

With advances in technology, a new era in troponin assays is approaching. Previous-
generation troponin assays have been used as diagnostic and prognostic markers in acute …

It is well established that clinicians cannot use clinical judgment alone to determine whether
an individual patient who presents to the emergency department has an acute coronary …

Background—Cardiac troponin and B-type natriuretic peptide (BNP) concentrations are
associated with adverse cardiovascular outcome in primary prevention populations …